Pharmaceutical composition for treating fatty liver disease

A pharmaceutical composition, comprising:

• a compound represented by Formula (I):
• wherein
• R1 is haloalkyl or non-aromatic carbocyclyl,
• R2 is a hydrogen atom or halogen,
• R3 is halogen,
• ring A is a group represented by the formula:
• -L1- is —O—(CH2)—, —(CH2)2—, —(CH2)—(CF2)—, or —(CF2)—(CH2)— (wherein a left bond is attached to the ring A and a right bond is attached to a group represented by the formula:
• R4 is alkyl or haloalkyl, and
• R5 is alkylcarbonyl or carbamoyl,
• or a pharmaceutically acceptable salt thereof;
• and
• at least one compound selected from the group consisting of obeticholic acid, semaglutide, and resmetirom or a pharmaceutically acceptable salt thereof.